Previously we reported that three imaging methods, dynamic contrast enhanced magnetic resonance imaging (DCE-MRI), T1ρ-MRI, and ultralow temperature NADH/flavoprotein fluorescence imaging (redox scanning), could differentiate the less metastatic human melanoma cell line A375P from a more metastatic line C8161 growing as mouse xenografts in nude mice (Li LZ et al. Adv. Exp. Med. Biol., 2007, 599:67-78; PNAS, 2009, 106:6608-6613). The more metastatic C8161 tumor was characterized by less blood perfusion/permeability, a more oxidized mitochondrial redox state in the tumor core, and a smaller T1ρ relaxation time constant averaged across the entire tumor section. In the current study, we have further probed the bioenergetic status and tissue microenvironment of these tumors by applying whole tumor phosphorous magnetic resonance spectroscopy (31P-MRS) to these two xenografts in a vertical bore 9.4-T Varian magnet. The phosphomonoester (PME)/βNTP ratio and intracellular pH value (pHi) were determined. The phosphomonoester (PME)/βNTP was higher in the more metastatic C8161 tumors (n=4) than in the less metastatic A375P tumors (n=4) (p < 0.1). No significant difference between the pHi of C8161 and A375P was observed.
Magnetic Resonance Spectroscopy Human Melanoma Cell Line C8161 Tumor Metastatic Melanoma Cell Line Bioenergetic Status
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.
Li, L.Z., et al Predicting melanoma metastatic potential by optical and magnetic resonance imaging. Adv Exp Med Biol, 2007. 599: p. 67-78.Google Scholar
Li, L.Z., et al Quantitative magnetic resonance and optical imaging biomarkers of melanoma metastatic potential. Proceedings of the National Academy of Sciences of the United States of America, 2009. 106(16): p. 6608-6613.PubMedCrossRefGoogle Scholar
Vaupel, P. and A. Mayer Hypoxia in cancer: significance and impact on clinical outcome. Cancer and Metastasis Reviews, 2007. 26(2): p. 225-239.PubMedCrossRefGoogle Scholar
Dewhirst, M.W., et al Relation between pO(2), P-31 magnetic resonance spectroscopy parameters and treatment outcome in patients with high-grade soft tissue sarcomas treated with thermoradiotherapy. International Journal of Radiation Oncology Biology Physics, 2005. 61(2): p. 480-491.CrossRefGoogle Scholar
Bhujwalla, Z.M., et al Estimations of intra- and extracellular volume and pH by P-31 magnetic resonance spectroscopy: effect of therapy on RIF-1 tumours. British Journal of Cancer, 1998. 78(5): p. 606-611.PubMedCrossRefGoogle Scholar
Zhou, R., et al Intracellular acidification of human melanoma xenografts by the respiratory inhibitor m-iodobenzylguanidine plus hyperglycemia: A P-31 magnetic resonance spectroscopy study. Cancer Research, 2000. 60(13): p. 3532-3536.PubMedGoogle Scholar
Shukla-Dave, A., et al Prediction of treatment response of head and neck cancers with P-31 MR spectroscopy from pretreatment relative phosphomonoester levels. Academic Radiology, 2002. 9(6): p. 688-694.PubMedCrossRefGoogle Scholar
Arias-Mendoza, F., M.R. Smith, and T.R. Brown, Predicting treatment response in non- Hodgkin’s lymphoma from the pretreatment tumor content of phosphoethanolamine plus phosphocholine. Academic Radiology, 2004. 11(4): p. 368-376.PubMedCrossRefGoogle Scholar
Gatenby, R.A. and R.J. Gillies Why do cancers have high aerobic glycolysis? Nature Reviews Cancer, 2004. 4(11): p. 891-899.PubMedCrossRefGoogle Scholar
Gatenby, R.A., et al Acid-mediated tumor invasion: a multidisciplinary study. Cancer Research, 2006. 66(10): p. 5216-5223.PubMedCrossRefGoogle Scholar